Promacta and Stomatitis - a phase IV clinical study of FDA data

Summary:

Stomatitis is reported as a side effect among people who take Promacta (eltrombopag olamine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lantus, and have Idiopathic thrombocytopenic purpura.

The phase IV clinical study analyzes which people have Stomatitis when taking Promacta. It is created by eHealthMe based on reports of 17,717 people who have side effects when taking Promacta from the FDA, and is updated regularly.

What is Promacta?

Promacta has active ingredients of eltrombopag olamine. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,758 Promacta users. Check the latest studies of Promacta.

What is Stomatitis?

Stomatitis (inflammation of mucous membrane of mouth) is found to be associated with 1,884 drugs and 2,011 conditions by eHealthMe. Check the latest studies of Stomatitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

17,717 people reported to have side effects when taking Promacta.
Among them, 28 people (0.16%) have Stomatitis.

Among these 28 people:

How long have people been on Promacta when they have Stomatitis? *

What is the gender of people who have Stomatitis when taking Promacta? *

female: 51.85 %
male: 48.15 %

What is the age of people who have Stomatitis when taking Promacta? *

What are other drugs people take besides Promacta? *

What are other side effects people have besides Stomatitis? *

Fatigue (feeling of tiredness): 5 people, 17.86%
Diarrhea: 5 people, 17.86%
Thrombocytopenia (decrease of platelets in blood): 5 people, 17.86%
Memory Loss: 4 people, 14.29%
Cough: 3 people, 10.71%
Headache (pain in head): 3 people, 10.71%
Oropharyngeal Pain: 3 people, 10.71%
Nausea (feeling of having an urge to vomit): 3 people, 10.71%
Weakness: 3 people, 10.71%
Haematemesis (vomiting of blood): 3 people, 10.71%

What are the existing conditions these people have? *

Thyroid Cancer: 2 people, 7.14%
Renal Cell Carcinoma (a kidney cancer): 2 people, 7.14%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 7.14%
Thrombocytopenia (decrease of platelets in blood): 1 person, 3.57%
Neoplasm Malignant (cancer tumour): 1 person, 3.57%
Multiple Myeloma (cancer of the plasma cells): 1 person, 3.57%
Hepatitis C: 1 person, 3.57%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 3.57%
Breast Cancer Female: 1 person, 3.57%
Breast Cancer: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Promacta and have Stomatitis?

- Check whether Stomatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Promacta:

Promacta (17,758 reports)

Stomatitis treatments and more:

Stomatitis (75,938 reports)

Browse all side effects of Promacta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stomatitis:

Stomatitis (1,884 drugs)

Browse all the conditions that are associated with Stomatitis:

Stomatitis (2,011 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eltrombopag olamine (the active ingredients of Promacta) and Promacta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.